Empaa-L (Empagliflozin + linagliptin) 10mg/5mg 28 tablets

Empaa-L (Empagliflozin 10mg + Linagliptin 5mg) Tablets

Dual-Action Treatment for Type 2 Diabetes

Empaa-L is a combination of Empagliflozin (SGLT2 inhibitor) and Linagliptin (DPP-4 inhibitor) designed to help lower blood sugar levels in adults with Type 2 diabetes. It works by increasing glucose excretion through urine and enhancing insulin production, leading to better blood sugar control without increasing the risk of hypoglycemia.

Key Benefits

✔ Lowers Blood Sugar Levels – Helps maintain stable glucose control.
✔ Reduces the Risk of Heart Complications – Supports heart and kidney health.
✔ Aids in Weight Management – Helps with weight loss by eliminating excess glucose.
✔ Once-Daily Convenience – Simplifies diabetes management.
✔ Dual Mechanism for Better Control – Combines two different modes of action for improved effectiveness.

How to Use

• Take one tablet daily, preferably in the morning.
• Swallow whole with water; do not crush or chew.
• Can be taken with or without food.
• Follow your doctor’s diet and exercise recommendations for best results.

Important Information

• Stay hydrated to prevent dehydration from increased urination.
• Monitor kidney function regularly, as Empagliflozin affects kidney performance.
• May cause mild urinary tract infections or genital infections due to increased sugar in urine.
• Not for patients with Type 1 diabetes or severe kidney disease.
• Consult your doctor before use if pregnant or breastfeeding.

Empaa-L provides an effective and convenient treatment for Type 2 diabetes, promoting better blood sugar control, heart health, and overall well-being.